Evidence map›Paper›PMID 30412681›Full record

ArticleBioanalysis2018

Quantitative profiling of cortisol metabolites in human urine by high-resolution accurate-mass MS.

Yi Wang, Naomi Fujioka, Chengguo Xing

Registry-linked trialAbstract read
In one paragraph

Article in Bioanalysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02500472 (Investigation of Kava Effects on the Metabolism of the Tobacco-specific Carcinogen 4-), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02500472 nacompletednot on this map

Investigation of Kava Effects on the Metabolism of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Humans

TypeinterventionalSponsorMasonic Cancer Center, University of MinnesotaRan2015 to 2018Enrolled24ConditionsTobacco SmokingArmsKava
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Cortisol Stability at 16 and 30 Years in Urine Specimens Stored at -20°C.American journal of human biology : the official journal of the Human Biology Council · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Opportunities and Challenges of Kava in Lung Cancer Prevention.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yi WangDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
Naomi FujiokaDivision of Hematology, Oncology & Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.
Chengguo XingDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
Dihydromethysticin (DHM) for Lung Cancer ChemopreventionR01CA193278 · NCI · UNIVERSITY OF MINNESOTA · PI XING, CHENGGUO · 2015 to 2019
$1.7M
NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA193278
6 · The paper itself

Abstract

Aim, materials & methods: Urinary cortisol profile has the potential as a diagnostic biomarker. We therefore developed a stable-isotope dilution ultraperformance chromatography multistage MS-based method to quantify cortisol and 16 metabolites in human urines. Results & conclusion: The LOD for cortisol and its metabolites ranges from 0.02 to 5.81 pg/μl urine. The inter- and intraday variations were 3.7-12.9% and 3.5-15.6%, respectively. Among the metabolites analyzed, significant person-to-person heterogeneity was observed, demonstrating the need for comprehensive metabolite profiling in diagnosis. Nevertheless, the glucuronides of dihydrocortisol, dihydrocortisone, tetrahydrocortisol, allo-tetrahydrocortisol and tetrahydrocortisone are the major ones. The sum of the glucuronidated and free forms constitute >93% of the metabolites analyzed, which is termed as total cortisol equivalent. Total cortisol equivalent may serve as a surrogate of cortisol secretion. Clinical trial registration number: NCT02500472.

Indexed as

BiomarkersChromatography, High Pressure LiquidGlucuronidesHumansHydrocortisoneMetabolic Networks and PathwaysSmokersSpectrometry, Mass, Electrospray IonizationStress, PsychologicalBiomarkersGlucuronidesHydrocortisonecortisol metabolismhigh-resolution accurate-mass MSstresstobaccourine biomarker

Identifiers

PMID30412681
PMCPMC6462871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.